Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
about
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits LeukemogenesisAnalysis of Jak2 catalytic function by peptide microarrays: the role of the JH2 domain and V617F mutationPhotocleavable peptide-conjugated magnetic beads for protein kinase assays by MALDI-TOF MSDifferential signaling networks of Bcr-Abl p210 and p190 kinases in leukemia cells defined by functional proteomics.Structure, regulation, signaling, and targeting of abl kinases in cancer.NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitorsABL1 fusion genes in hematological malignancies: a review.Deciphering enzyme function using peptide arrays.Tyrosine kinase gene fusions in cancer: translating mechanisms into targeted therapies.The molecular basis of T cell acute lymphoblastic leukemiaSrc family kinases and their role in hematological malignancies.NUP214 fusion genes in acute leukemia (Review).The genetics and molecular biology of T-ALL.NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic LeukemiaNucleoporin Gene Fusions and Hematopoietic Malignancies
P2860
Q27675049-6CF3AC21-5EC6-4ECC-80FA-A6A80046B008Q28477794-12D6D90C-D1E5-466B-BE7C-0A4C6DD14681Q33699182-AAFAD46B-BDC3-4B34-8CF6-27DC33FCBAC9Q33899740-976BD0F3-DFE9-41FC-BF15-99C3F1F73FDEQ36443429-949192EB-19D9-4EC2-ADDF-55A34F317591Q37216300-D3FE771C-5D51-4AF2-9D7E-6996EFABF3C7Q37857340-74678778-F291-486D-B9E7-BCC4CA084971Q37878429-89AA5883-D23C-4B13-A3E4-5ECB2FF78744Q37919976-176B9BD5-341B-478D-99AB-C2B0F54738CCQ38047834-31DE261E-0B9C-46A8-81F7-81BD2BA79FDAQ38217719-D779858D-B852-475D-941D-569B0515A6DEQ38239669-9AA3BD94-C0FE-40BE-80F3-1E22CD61D57FQ39099555-AD503EF2-2C36-42AF-BD87-6F06741AD016Q39122858-534DE8A9-CBAA-4236-B442-16DED4D06FC7Q41660964-07864095-38F9-4B56-BC5A-6AC3F22B3E64Q41904096-DDE2F272-6BBB-463B-929C-3EB04EE902EAQ47094344-1B696C87-0441-496C-B97E-C1484D86D6C7Q58785945-83011EB4-A34E-467D-AF1C-261851CA14B1Q59072645-4EE85963-6F6D-4876-90E4-433D9EF47F69
P2860
Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@en
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@nl
type
label
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@en
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@nl
prefLabel
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@en
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@nl
P50
P356
P1433
P1476
Intrinsic differences between ...... R-ABL1 fusion protein kinases.
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2008.242
P577
2008-09-11T00:00:00Z